Moderna, J&J Make Case for Covid Boosters Ahead of FDA Panel (2)

Oct. 12, 2021, 3:52 PM

Moderna Inc. and Johnson & Johnson said that data they’ve gathered supports the need for booster shots for their Covid-19 vaccines, ahead of a key regulatory meeting later this week.

A panel of scientific experts who advise the U.S. Food and Drug Administration on vaccines is scheduled to meet Thursday and Friday to weigh the evidence for booster doses for each of the two vaccines. The regulator has already authorized a booster for the Covid shot made by Pfizer Inc. and BioNTech SE for those 65 and older and other at-risk adults.

The Biden administration has been pushing to make ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.